Keyphrases
Perfluorohexanoic Acid (PFHxA)
100%
Hepatic Steatosis
100%
Mechanistic Action
100%
Lipid Transport
100%
Environmental Exposure
7%
Energy Production
7%
Molecular Analysis
7%
CD-1 Mice
7%
Serum Levels
7%
Disease Progression
7%
Dose Effect
7%
Lipid Metabolism
7%
Liver
7%
Consumer Products
7%
Fatty Acids
7%
Fatty Acid Oxidation
7%
Gene Expression Level
7%
Histological Analysis
7%
Triglycerides
7%
Hepatotoxicity
7%
Hepatocytes
7%
Induced Toxicity
7%
Non-alcoholic Fatty Liver Disease (NAFLD)
7%
Human Samples
7%
Steatosis
7%
Young Males
7%
Body Fluids
7%
Lipoprotein Lipase
7%
Low-density Lipoprotein
7%
Sample Analysis
7%
Liver Sections
7%
Hepatic Lipid Metabolism
7%
Mitochondrial Oxidation
7%
Cellular Targets
7%
Pathological Manifestations
7%
Fatty Acid Translocase
7%
Human Liver Diseases
7%
Cluster of Differentiation 36 (CD36)
7%
Biochemistry, Genetics and Molecular Biology
Perfluorooctanesulfonic Acid
100%
Lipid Transport
100%
Lipid Metabolism
15%
Liquid
7%
Mitochondrial Respiration
7%
Gene Expression Level
7%
Beta Oxidation
7%
Triglyceride
7%
Blood Level
7%
Carrier Protein
7%
Hepatocyte
7%
Energy Yield
7%
Animal Experiment
7%
Diacylglycerol Lipase
7%
Very Low-Density Lipoprotein
7%
CD-1 Mouse
7%
Mitochondrial Membrane Transport Protein
7%
Lipid Liver Level
7%
Translocase
7%
CD36
7%
Pharmacology, Toxicology and Pharmaceutical Science
Perfluorooctanesulfonic Acid
100%
Fatty Liver
100%
Fatty Acid
15%
Environmental Exposure
7%
CD-1 Mouse
7%
Biological Marker
7%
Disease Exacerbation
7%
Triacylglycerol
7%
Hepatotoxicity
7%
Liver Disease
7%
Hepatomegaly
7%
Nonalcoholic Fatty Liver
7%
Steatosis
7%
Very Low Density Lipoprotein
7%
Lipoprotein Lipase
7%
CD36 Antigen
7%